NHS in England is ‘deteriorating’
March 26, 2015Sales and Marketing Conservatives, England, Labour, NHS, coalition, election, government, liberal
Leading UK healthcare think tank The King’s Fund has published its second report on the NHS under the present government …
NICE decisions made on Bayer, Celgene and Boehringer drugs
March 26, 2015Sales and Marketing Bayer, Boehringer, Celgene, NHS, Xarelto, imnovid, jardiance
In final guidance NICE has recommended Bayer’s Xarelto and Boehringer’s Jardiance for NHS funding, but not Celgene’s Imnovid. Bayer’s Xarelto …
Two new directors for The Purple Agency
March 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Jenkins, Terri Martin, purple agency
UK communications firm The Purple Agency has appointed two new directors to its healthcare team. Andrew Jenkins (pictured) who was …
GSK seeks development proposals from academics
March 25, 2015Research and Development, Sales and Marketing GSK, academics, fast track challenge, proposals
Registration has opened for GlaxoSmithKline’s third annual Discovery Fast Track challenge, which sees the company searching for new drug discovery …
FDA to review homeopathy rules
March 25, 2015Research and Development, Sales and Marketing Australian Government’s National Health and Medical Research Council, FDA, homeopathy
The FDA is to hold a public meeting to “obtain information and comments from stakeholders” on the use of homeopathic …
NHS launches mental health apps library
March 25, 2015Medical Communications, Sales and Marketing England, NHS, apps, choices, digital, kitemark, online
NHS England has launched a directory of digital services it endorses for the treatment of mental health, in the first …
NICE names new non-executive director
March 25, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, tim irish
The Department of Health has appointed Tim Irish as a non-executive director of the National Institute for Health and Care …
Merck’s Keytruda trial stopped early after beating BMS’ Yervoy on survival
March 25, 2015Research and Development, Sales and Marketing BMS, Merck, Yervoy, ipilimumab, keytruda, pembrolizumab
A trial comparing two potential blockbuster cancer treatments has been stopped early, after Merck’s Keytruda beat BMS’ Yervoy in a …
AstraZeneca and Harvard team up for diabetes research
March 25, 2015Research and Development, Sales and Marketing AZ, AstraZeneca, Havard, cardiovascular, diabetes, metabolic
AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …
J&J blood cancer drug gets UK launch
March 25, 2015Sales and Marketing Cancer, J&J, JJ, Janssen, NICE, Velcade, bortezomib, mcl, nhl
Johnson and Johnson’s pharma unit Janssen is launching Velcade in the UK for the first-line treatment of Mantle Cell Lymphoma …
Generic version of Pfizer’s Lyrica launched
March 25, 2015Sales and Marketing CCG, Lyrica, NHS, Pfizer, consilient health, pregabalin, rewisca
A UK pharma firm has launched a cut-price version of Pfizer’s Lyrica along with a bespoke supply chain to ensure …
Teva hires new business development head
March 25, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, timothy wright
Teva Pharmaceutical Industries has confirmed the appointment of Timothy Wright to its executive leadership team to head up business development, …
Takeda buys license to ImmunoGen cancer tech
March 24, 2015Research and Development, Sales and Marketing ADC, Immunogen, Takeda, antibody, conjugate, merger
Takeda has licensed the exclusive rights to use ImmunoGen’s popular antibody-drug conjugate (ADC) technology to develop new cancer drugs. The …
Novo Nordisk obesity drug gets EU approval
March 24, 2015Sales and Marketing EMA, EU, FDA, Victoza, liraglutide, obesity, saxenda
Novo Nordisk’s obesity drug Saxenda has been approved by the European Commission for use across the EU. This approval follows …
Lilly and Boehringer diabetes drug sees US launch
March 24, 2015Sales and Marketing Boehringer, Glyxambi, Tradjenta, diabetes, empagliflozin/linagliptin, lilly, linagliptin
Lilly and Boehringer Ingelheim’s combo diabetes drug Glyxambi is now available to treat adult patients in the US. Glyxambi (empagliflozin/linagliptin) …
FDA lifts ban on Pfizer Lilly pain study
March 24, 2015Research and Development, Sales and Marketing Cancer, FDA, Pfizer, lilly, pain, tanezumab
Pfizer and Eli Lilly will resume Phase III clinical trials of tanezumab following the FDA lifting a ban on trials …
Chief executive promotion at Merck KGaA
March 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Karl-Ludwig Kley, Merck, Merck KGaA, Merck Serono, Stefan Oschmann, chief executive
Merck KGaA is to promote its deputy chief executive Stefan Oschmann to replace Karl-Ludwig Kley in the top job next …
EMA elects new vice-chair
March 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Christa Wirthumer-Hoche, EMA
The European Medicines Agency has elected Dr Christa Wirthumer-Hoche, the head of the Austrian Medicines and Medical Devices Agency, as …
AbbVie invests $30 million to expand in Puerto Rico
March 23, 2015Manufacturing and Production, Sales and Marketing AbbVie, Alzheimer's, Puerto Rico, barceloneta, c2n
AbbVie is investing $30 million to expand one of its sites in Puerto Rico, and is also backing a promising …
Google files patent for cancer combating wearable
March 23, 2015Medical Communications, Sales and Marketing Cancer, Nanoparticle Phoresis, google, google x, nano, oncology, wearable, wipo
Google has filed a patent application for a new cancer-fighting wearable device which it says targets the cells in the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
